Skip to main content

Dr. Reddy's launches generic asthma, allergy, bronchospasm drug

9/27/2012

HYDERABAD, India — Dr. Reddy's Labs has launched a generic drug for treating asthma and allergies, and preventing bronchospasm during exercise, the company said.


The Indian company announced the launch of montelukast sodium oral granules in the 4-mg strength in unit-dose cartons of 30 packets.


The drug is a version of Merck's Singulair oral granules, which had sales of about $61 million during the 12-month period ended in July, according to IMS Health.




Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

X
This ad will auto-close in 10 seconds